hydroquinine Report issue

Small molecule Experimental
AACT ChEMBL Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

dihydroquinidine | dihydroquinine | hydroconquinine | hydroquinidine | hydroquinidine, (1beta, 3alpha,4beta,8alpha,9r)-isomer | hydroquinidine, (1beta,3alpha,4beta,9s)-isomer | hydroquinidine, (1beta,4beta,9s)-(+-)-isomer | hydroquinidine, (3alpha,9s)-(+-)-isomer | hydroquinidine, (8alpha,9r)-isomer | hydroquinidine, (8alpha,9s)-isomer | hydroquinidine, (9r)-isomer | hydroquinidine, (9s)-(+-)-isomer | hydroquinidine dihydrochloride, (1beta,4beta,3s)-(+-)-isomer | hydroquinidine dihydrochloride, (3alpha,9s)-(+-)-isomer | hydroquinidine hcl | hydroquinidine hydrochloride | hydroquinidine, (+-)-isomer | hydroquinidine monosulfate | hydroquinidine monosulfate, (1beta,3alpha,4beta,8alpha,9r)-isomer | hydroquinidine monosulfate, (1beta,3alpha,4beta,9s)-isomer | hydroquinidine sulfate | hydroquinidine sulfate, (9s)-isomer | hydroquinine | lcn 834 | lcn-834 | lentoquine | sérécor

Organizations (18)

Research & Development (18)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (2)


 

Brugada Syndrome (Phase 3)

Hyperpigmentation ()

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial Organizations: 18

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue